Virtus Biotech ETF
BBPETF · NYSE Arca
$106.22
+$1.33 (+1.27%)
EOD Oct 28, 2026
Key facts
- Expense ratio
- 0.6%
- Dividend yield (TTM)
- 0.00%
- Distributions
- Irregular
- Fund net assets (Jul 2026)
- $99M
- Stocks held
- 67
- Other positions
- 1
- Turnover (last fiscal year)
- 17%
- 52-week range
- $72.81 to $110.05
Top 10 holdings
All holdings19.6% of assets in ten stocks, as of Jul 31, 2026
| Company | Weight | Quality |
|---|---|---|
| 3.34% | 40 | |
| 1.97% | 71 | |
| 1.95% | 40 | |
| 1.94% | 0 | |
| 1.87% | 27 | |
| 1.77% | 10 | |
| 1.72% | 54 | |
| 1.71% | 54 | |
| 1.69% | 74 | |
| 1.65% | 30 |
Sector allocation
Share of the fund's assets
- Healthcare96.9%
- Industrials1.5%
Scores of what it owns
Every holding's scoreEach holding's score, weighted by its size in the fund
10% of the fund's stock weight sits in companies with a Quality score above 75, 63% in companies below 50.
Where it invests
Stock weight by the company's home country
- United States83.9%
- Cayman Islands3.6%
- United Kingdom3.6%
- Switzerland3.0%
- Bermuda1.6%
- Denmark1.5%
- Germany1.4%
- Canada1.3%
Growth of $10,000
With and without the dividends reinvested
Dividend
Dividend historyBBP has not paid a dividend in the last twelve months; the last payment was ex-dividend Dec 20, 2017.
BBP questions
What does BBP invest in?+
Virtus Biotech ETF is an exchange-traded fund. Its largest holdings are Crinetics Pharmaceuticals Inc. (3.34%), Kiniksa Pharmaceuticals International, plc (1.97%), Verastem Inc. (1.95%).
What is BBP's expense ratio?+
0.6% a year, as stated in the fund's latest shareholder report filed with the SEC. On a $10,000 investment that is about $60.00 a year.
How good are the companies BBP owns?+
Weighted by position size, the stocks in BBP average a Quality score of 42 out of 100. 10% of the fund's stock weight sits in companies scoring above 75, 63% in companies below 50. The score is computed from each company's SEC filings; the methodology page lists every check.
Holdings: the fund's latest SEC Form N-PORT, as of Jul 31, 2026. Expense ratio, turnover and returns: the fund's shareholder report (SEC Form N-CSR) for the period to n/a. Net assets: SEC Form N-PORT. Quality scores: computed by Intrinsiqq from each company's SEC filings (methodology). Price: end of day Oct 28, 2026.